Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Wuxi Pharma Tech Eyes Local Collaboration

This article was originally published in PharmAsia News

Executive Summary

Leading Chinese CRO Wuxi Pharma Tech has partnered with more than 80 major pharmaceutical corporations worldwide in conducting R&D for new drugs. However, it has yet to work with local pharmaceutical enterprises in China, and expressed interest in collaborating with domestic partners. Because of the high cost of R&D outsourcing, local companies mainly produce generic drugs rather than conduct research by R&D outsourcing. Analysts believe the next five years will see China becoming one of the top medical consumers globally, and new CROs are set to change the concept of drug manufacturing in the country. (Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts